Latest Neurotech International (ASX:NTI) News
Page 4
Page 4 of 4
Neurotech’s NTI164 Shows Rapid Absorption and Safety in Human PK Study
2 June 2025
Neurotech’s NTI164 Clears Key Safety Hurdle in 28-Day Toxicology Trials
5 May 2025
Neurotech Accelerates Pediatric Cannabinoid Therapy with European Partner
13 Feb 2025
Neurotech Boosts Cash Reserves with $2.44M R&D Tax Refund
31 Jan 2025
Neurotech Advances Rett Syndrome Therapy with FDA Orphan Drug Nod
29 Jan 2025